What is Phenixfin's earnings per share (EPS)?

Phenixfin (PFXNZ) reported diluted earnings per share of $2.06 for fiscal year 2025. This represents a -77.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Phenixfin Financials

PFXNZ

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE September

This page shows Phenixfin (PFXNZ) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 19/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Phenixfin's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage

Phenixfin carries a low D/E ratio of 0.97, meaning only $0.97 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 82/100, indicating a strong balance sheet with room for future borrowing.

Returns

Phenixfin's ROE of 2.6% shows moderate profitability relative to equity, earning a score of 30/100. This is down from 11.6% the prior year.

Piotroski F-Score Weak

2/9

Phenixfin passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality Low Quality

-16.20x

For every $1 of reported earnings, Phenixfin generates $-16.20 in operating cash flow (-$67.3M OCF vs $4.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

$4.2M

YoY-77.7%

Phenixfin reported $4.2M in net income in fiscal year 2025. This represents a decrease of 77.7% from the prior year.

EPS (Diluted)

$2.06

YoY-77.4%

Phenixfin earned $2.06 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 77.4% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$7.3M

YoY-89.2%

Phenixfin held $7.3M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

YoY-0.8%

Phenixfin had 2M shares outstanding in fiscal year 2025. This represents a decrease of 0.8% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

2.6%

YoY-9.0pp

Phenixfin's ROE was 2.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 9.0 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$801K

YoY-66.2%

Phenixfin spent $801K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 66.2% from the prior year.

Capital Expenditures

N/A

PFXNZ Income Statement

Metric	FY25	FY24	FY23	FY22	FY21
Revenue	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$1.2M+13.3%	$1.1M+11.3%	$983K-10.9%	$1.1M+9.0%	$1.0M
Operating Income	N/A	N/A	N/A	N/A	N/A
Interest Expense	$10.3M+55.5%	$6.6M+19.5%	$5.5M+8.2%	$5.1M-11.8%	$5.8M
Income Tax	N/A	N/A	N/A	N/A	N/A
Net Income	$4.2M-77.7%	$18.6M-30.8%	$26.9M+540.8%	-$6.1M	N/A
EPS (Diluted)	$2.06-77.4%	$9.13-29.1%	$12.87+589.4%	$-2.63-647.9%	$0.48

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$360K	N/A	$398K+29.5%	$308K+38.8%	$222K	N/A	$227K-27.0%	$311K
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$2.4M	N/A	$2.7M+3.1%	$2.6M+1.3%	$2.5M	N/A	$1.7M+9.9%	$1.6M
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$4.8M	N/A	-$1.5M-67.1%	-$896K-136.4%	$2.5M	N/A	$2.6M-51.4%	$5.4M
EPS (Diluted)	$-2.38	N/A	$-0.74-68.2%	$-0.44-136.1%	$1.22	N/A	$1.29-50.8%	$2.62

PFXNZ Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21
Total Assets	$316.9M+4.7%	$302.8M+26.3%	$239.7M+9.5%	$218.9M	N/A
Current Assets	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$7.3M-89.2%	$67.6M+1026.7%	$6.0M-73.7%	$22.8M-67.2%	$69.4M
Inventory	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	$3.9M	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$156.1M+9.6%	$142.4M+53.2%	$93.0M-5.1%	$98.0M	N/A
Current Liabilities	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A
Total Equity	$160.8M+0.3%	$160.3M+9.3%	$146.7M+21.4%	$120.8M-15.9%	$143.7M
Retained Earnings	-$543.9M+0.1%	-$544.6M+0.6%	-$548.1M+1.2%	-$554.6M	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$307.4M-3.0%	$316.9M+3.3%	$306.8M+2.0%	$300.7M-3.6%	$311.9M+3.0%	$302.8M+22.9%	$246.3M-0.6%	$247.7M
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$3.4M-53.4%	$7.3M0.0%	$7.3M-16.1%	$8.7M+20.8%	$7.2M-89.3%	$67.6M+659.6%	$8.9M-53.4%	$19.1M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$151.6M-2.9%	$156.1M+4.0%	$150.1M+5.9%	$141.7M-5.0%	$149.2M+4.7%	$142.4M+54.7%	$92.1M-1.4%	$93.4M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$155.8M-3.1%	$160.8M+2.6%	$156.7M-1.4%	$159.0M-2.3%	$162.8M+1.5%	$160.3M+4.0%	$154.2M0.0%	$154.3M
Retained Earnings	-$548.6M-0.9%	-$543.9M+0.6%	-$547.4M-0.3%	-$545.9M-0.7%	-$542.1M+0.5%	-$544.6M-1.2%	-$538.2M0.0%	-$538.2M

PFXNZ Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21
Operating Cash Flow	-$67.3M-518.1%	$16.1M+177.8%	-$20.7M+29.3%	-$29.3M-130.8%	$95.1M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$7.0M-84.5%	$45.5M+1058.3%	$3.9M+122.6%	-$17.4M+78.9%	-$82.2M
Dividends Paid	$2.9M+9.2%	$2.6M	N/A	$266K	N/A
Share Buybacks	$801K-66.2%	$2.4M+124.1%	$1.1M-93.8%	$17.0M+106.8%	$8.2M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$2.0M+31.5%	-$3.0M+56.8%	-$6.9M-178.2%	$8.8M+113.3%	-$66.3M-860.7%	$8.7M+204.7%	-$8.3M-192.9%	$9.0M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	-$1.8M-161.6%	$3.0M-45.2%	$5.5M+174.9%	-$7.3M-223.8%	$5.9M-88.2%	$50.0M+2680.6%	-$1.9M+3.6%	-$2.0M
Dividends Paid	N/A	$0	$0	N/A	N/A	$0	N/A	N/A
Share Buybacks	$183K+3731.5%	$5K	N/A	N/A	N/A	$0-100.0%	$31K-98.3%	$1.8M

PFXNZ Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A
Return on Equity	2.6%-9.0pp	11.6%-6.7pp	18.4%+23.4pp	-5.1%	N/A
Return on Assets	1.3%-4.8pp	6.2%-5.1pp	11.2%+14.0pp	-2.8%	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.97+0.1	0.89+0.3	0.63-0.2	0.81	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-3.1%	N/A	-1.0%-0.4pp	-0.6%-2.1pp	1.5%	N/A	1.7%-1.8pp	3.5%
Return on Assets	-1.6%	N/A	-0.5%-0.2pp	-0.3%-1.1pp	0.8%	N/A	1.1%-1.1pp	2.2%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.970.0	0.97+0.0	0.96+0.1	0.89-0.0	0.92+0.0	0.89+0.3	0.600.0	0.61
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Frequently Asked Questions

Is Phenixfin profitable?

Yes, Phenixfin (PFXNZ) reported a net income of $4.2M in fiscal year 2025.

What is Phenixfin's return on equity (ROE)?

Phenixfin (PFXNZ) has a return on equity of 2.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Phenixfin's operating cash flow?

Phenixfin (PFXNZ) generated -$67.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Phenixfin's total assets?

Phenixfin (PFXNZ) had $316.9M in total assets as of fiscal year 2025, including both current and long-term assets.

Does Phenixfin buy back shares?

Yes, Phenixfin (PFXNZ) spent $801K on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Phenixfin have outstanding?

Phenixfin (PFXNZ) had 2M shares outstanding as of fiscal year 2025.

What is Phenixfin's debt-to-equity ratio?

Phenixfin (PFXNZ) had a debt-to-equity ratio of 0.97 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Phenixfin's return on assets (ROA)?

Phenixfin (PFXNZ) had a return on assets of 1.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Phenixfin's cash runway?

Based on fiscal year 2025 data, Phenixfin (PFXNZ) had $7.3M in cash against an annual operating cash burn of $67.3M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Phenixfin's Piotroski F-Score?

Phenixfin (PFXNZ) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Phenixfin's earnings high quality?

Phenixfin (PFXNZ) has an earnings quality ratio of -16.20x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Phenixfin?

Phenixfin (PFXNZ) scores 19 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.